ClearPoint Neuro Inc. (CLPT)
14.66
-0.74 (-4.81%)
At close: Jan 14, 2025, 3:59 PM
15.00
2.32%
Pre-market Jan 15, 2025, 08:35 AM EST
undefined% (undefined)
| Bid | 13.97 |
| Market Cap | 404.39M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.69 |
| PE Ratio (ttm) | -21.25 |
| Forward PE | n/a |
| Analyst | Strong Buy |
| Ask | 16 |
| Volume | 282,163 |
| Avg. Volume (20D) | 240,450 |
| Open | 15.44 |
| Previous Close | 15.40 |
| Day's Range | 14.30 - 15.93 |
| 52-Week Range | 5.11 - 17.47 |
| Beta | undefined |
About CLPT
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into...
Industry Medical - Devices
Sector Healthcare
IPO Date May 22, 2012
Employees 107
Stock Exchange NASDAQ
Ticker Symbol CLPT
Website https://www.clearpointneuro.com
Analyst Forecast
According to 2 analyst ratings, the average rating for CLPT stock is "Strong Buy." The 12-month stock price forecast is $12, which is a decrease of -18.14% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
Next Earnings Release
ClearPoint Neuro Inc. is scheduled to release its earnings on Mar 11, 2025,
during market hours.
Analysts project revenue of $8.23M, reflecting a 20.85% YoY growth and earnings per share of -0.16, making a -15.79% decrease YoY.
Analysts project revenue of $8.23M, reflecting a 20.85% YoY growth and earnings per share of -0.16, making a -15.79% decrease YoY.
4 months ago ·
Source
+8.97%
ClearPoint Neuro shares are trading higher after t...
Unlock content with
Pro Subscription
5 months ago ·
Source
+40.68%
ClearPoint Neuro shares are trading higher after the company reported better-than-expected Q2 financial results.
